Compare · DWMC vs PBIO

DWMC vs PBIO

Side-by-side comparison of AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC) and Pressure BioSciences, Inc. (PBIO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DWMC and PBIO operate in n/a (n/a), so they compete in similar markets.
MetricDWMCPBIO
Company
AdvisorShares Dorsey Wright Micro-Cap ETF
Pressure BioSciences, Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
DWMC

AdvisorShares Dorsey Wright Micro-Cap ETF

The investment seeks long term capital appreciation. The fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing primarily in U.S.-traded equity securities consisting of common and preferred stock and American Depositary Receipts ("ADRs"). ADRs are securities traded on a local exchange stock exchange that represent interests in securities issued by a foreign publicly listed company. Under normal circumstances, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in micro-cap securities.

PBIO

Pressure BioSciences, Inc.

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. It serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. Pressure BioSciences, Inc. has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts.